ClearPoint Neuro (CLPT) Other Non-Current Assets (2011 - 2026)
ClearPoint Neuro's (CLPT) quarterly Other Non-Current Assets came in at $1.6 million in Q1 2026, up 1012.16% year-on-year from $148000.0 in Q1 2025, and down 3.29% quarter-over-quarter from $1.7 million in Q4 2025.
ClearPoint Neuro (CLPT) Other Non-Current Assets (2011 - 2026) Analysis & Trends
ClearPoint Neuro has disclosed Other Non-Current Assets across 16 years of filings, most recently posting $1.6 million for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $1.6 million, up 1012.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 1012.16% YoY), and the FY2025 annual result was $1.7 million, up 131.56% from the prior year.
- Other Non-Current Assets came in at $1.6 million for Q1 2026 at ClearPoint Neuro, down from $1.7 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.7 million in Q4 2025 to a low of $94000.0 in Q1 2022.
- The 5-year median for Other Non-Current Assets is $148000.0 (2024), against an average of $427882.4.
- Across the five-year window, Other Non-Current Assets slumped 37.75% in 2022 and jumped 1012.16% in 2026, its largest moves.
- ClearPoint Neuro's Other Non-Current Assets stood at $131000.0 in 2022, then decreased by 16.79% to $109000.0 in 2023, then jumped by 574.31% to $735000.0 in 2024, then jumped by 131.56% to $1.7 million in 2025, then fell by 3.29% to $1.6 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.6 million (Q1 2026), $1.7 million (Q4 2025), and $959000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | ClearPoint Neuro | 524.46 Mn | 488.86 Mn | 7.76 Mn | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.65 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | 959,000.00 |
| Jun 30, 2025 | 720,000.00 |
| Mar 31, 2025 | 148,000.00 |
| Dec 31, 2024 | 735,000.00 |
| Sep 30, 2024 | 148,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Mar 31, 2024 | 149,000.00 |
| Dec 31, 2023 | 109,000.00 |
| Sep 30, 2023 | 109,000.00 |
| Jun 30, 2023 | 156,000.00 |
| Mar 31, 2023 | 131,000.00 |
| Dec 31, 2022 | 131,000.00 |
| Sep 30, 2022 | 94,000.00 |
| Jun 30, 2022 | 94,000.00 |
| Mar 31, 2022 | 94,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 86,000.00 |
| Jun 30, 2021 | 151,000.00 |